In To: Board of Supervisors
From: Dr. Grant Colfax, Health Services Director
Report Title: Purchase Order with Priority Healthcare Distribution, Inc. (dba Curascript Specialty Distribution)
?Recommendation of the County Administrator ? Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with Priority Healthcare Distribution, Inc. (dba Curascript Specialty Distribution) in an amount not to exceed $379,835 for the purchase of the opioid use disorder medication Sublocade for the Martinez Detention Facility for the period from July 1, 2026 through June 30, 2029.
FISCAL IMPACT:
Approval of this action will result in expenditures of up to $379,835 over a three-year period and will be funded by the Opioid Settlement Funds.
BACKGROUND:
Priority Healthcare Distribution, Inc. is a pharmaceutical company that provides Sublocade that is used for Opioid Use Disorders (OUD). Detention Health Services will treat patients with OUD and a history of diversion within the Detention setting utilizing Sublocade Injectable. Treatment with Sublocade is effective in reducing withdrawal symptoms and craving for ongoing opiate abuse. In addition, the use of Sublocade will eliminate patients with OUD and diversion from being detoxed off the medication and, therefore, potentially overdosing on Fentanyl within the detention setting.
On May 30, 2025, the Purchasing Agent issued Purchase Order #32757 with Priority Healthcare Distribution, Inc (dba Curascript Specialty Distribution) in the amount of $111,271 to purchase Sublocade for Detention Health Services for the period from January 1, 2025 through May 31, 2026.
On April 14, 2026, the Board of Supervisors approved agenda item C.63 to execute an amendment to Purchase Order #32757 with Priority Healthcare Distribution, Inc. (dba Curascript Specialty Distribution) to increase the total payment limit to $241,271 wit...
Click here for full text